دورية أكاديمية
أعرض في EDS

Synthesis and evaluation of orally active small molecule HIV-1 Nef antagonists.

التفاصيل البيبلوغرافية
العنوان: Synthesis and evaluation of orally active small molecule HIV-1 Nef antagonists.
المؤلفون: Emert-Sedlak LA; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of School of Medicine, Pittsburgh, PA 15219 USA., Loughran HM; Fox Chase Chemical Diversity Center, Inc., Doylestown, PA 18902 USA., Shi H; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of School of Medicine, Pittsburgh, PA 15219 USA., Kulp JL 3rd; Conifer Point Pharmaceuticals, Doylestown, PA 18902 USA., Shu ST; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of School of Medicine, Pittsburgh, PA 15219 USA., Zhao J; Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA 15261 USA.; University of Pittsburgh Drug Discovery Institute, Pittsburgh, PA 15260 USA., Day BW; Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA 15261 USA.; University of Pittsburgh Drug Discovery Institute, Pittsburgh, PA 15260 USA.; Department of Chemistry, University of Pittsburgh, Pittsburgh, PA 15260 USA., Wrobel JE; Fox Chase Chemical Diversity Center, Inc., Doylestown, PA 18902 USA., Reitz AB; Fox Chase Chemical Diversity Center, Inc., Doylestown, PA 18902 USA., Smithgall TE; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of School of Medicine, Pittsburgh, PA 15219 USA.
المصدر: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2016 Mar 01; Vol. 26 (5), pp. 1480-1484. Date of Electronic Publication: 2016 Jan 21.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3405 (Electronic) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE
أسماء مطبوعة: Publication: Oxford : Elsevier Science Ltd
Original Publication: Oxford ; New York : Pergamon Press, c1991-
مواضيع طبية MeSH: Anti-HIV Agents/*chemical synthesis , Anti-HIV Agents/*pharmacology , Small Molecule Libraries/*pharmacology , nef Gene Products, Human Immunodeficiency Virus/*antagonists & inhibitors, Administration, Oral ; Animals ; Anti-HIV Agents/administration & dosage ; Binding Sites/drug effects ; Dose-Response Relationship, Drug ; HIV-1/drug effects ; Mice ; Microbial Sensitivity Tests ; Models, Molecular ; Molecular Conformation ; Molecular Docking Simulation ; Small Molecule Libraries/administration & dosage ; Small Molecule Libraries/chemical synthesis ; Structure-Activity Relationship ; Tumor Cells, Cultured ; Virus Replication/drug effects
مستخلص: The HIV-1 Nef accessory factor enhances viral replication and promotes immune system evasion of HIV-infected cells, making it an attractive target for drug discovery. Recently we described a novel class of diphenylpyrazolodiazene compounds that bind directly to Nef in vitro and inhibit Nef-dependent HIV-1 infectivity and replication in cell culture. However, these first-generation Nef antagonists have several structural liabilities, including an azo linkage that led to poor oral bioavailability. The azo group was therefore replaced with either a one- or two-carbon linker. The resulting set of non-azo analogs retained nanomolar binding affinity for Nef by surface plasmon resonance, while inhibiting HIV-1 replication with micromolar potency in cell-based assays without cytotoxicity. Computational docking studies show that these non-azo analogs occupy the same predicted binding site within the HIV-1 Nef dimer interface as the original azo compound. Computational methods also identified a hot spot for inhibitor binding within this site that is defined by conserved HIV-1 Nef residues Asp108, Leu112, and Pro122. Pharmacokinetic evaluation of the non-azo B9 analogs in mice showed that replacement of the azo linkage dramatically enhanced oral bioavailability without substantially affecting plasma half-life or clearance. The improved oral bioavailability of non-azo diphenylpyrazolo Nef antagonists provides a starting point for further drug lead optimization in support of future efficacy testing in animal models of HIV/AIDS.
(Copyright © 2016 Elsevier Ltd. All rights reserved.)
References: Microbes Infect. 2002 Feb;4(2):189-99. (PMID: 11880052)
Cell. 1996 Jun 14;85(6):931-42. (PMID: 8681387)
Chem Biol. 2013 Jan 24;20(1):82-91. (PMID: 23352142)
ChemMedChem. 2012 Jul;7(7):1217-29. (PMID: 22555953)
PLoS One. 2012;7(2):e32561. (PMID: 22393415)
Curr HIV Res. 2011 Oct;9(7):531-42. (PMID: 22103837)
J Am Chem Soc. 2011 Jul 20;133(28):10740-3. (PMID: 21682273)
Prog Med Chem. 2011;50:1-47. (PMID: 21315927)
J Virol. 2006 Feb;80(3):1311-20. (PMID: 16415008)
Bioorg Med Chem Lett. 2014 Apr 1;24(7):1702-6. (PMID: 24650642)
Drug Discov Today Technol. 2013 Dec;10(4):e523-9. (PMID: 24451644)
Retrovirology. 2013;10:135. (PMID: 24229420)
Lancet. 2013 Nov 2;382(9903):1525-33. (PMID: 24152939)
Chem Biol Drug Des. 2013 Jun;81(6):730-41. (PMID: 23405965)
Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4653-8. (PMID: 9114046)
Curr HIV Res. 2005 Jan;3(1):87-94. (PMID: 15638726)
Expert Opin Pharmacother. 2006 Aug;7(12):1541-54. (PMID: 16872258)
Cell Host Microbe. 2008 Jun 12;3(6):388-98. (PMID: 18541215)
Retrovirology. 2008;5:84. (PMID: 18808677)
ACS Chem Biol. 2009 Nov 20;4(11):939-47. (PMID: 19807124)
معلومات مُعتمدة: AI102704 United States AI NIAID NIH HHS; R01 AI102724 United States AI NIAID NIH HHS; R01 AI057083 United States AI NIAID NIH HHS; R41 GM112516 United States GM NIGMS NIH HHS; K01 OD018431 United States OD NIH HHS; R42 GM112516 United States GM NIGMS NIH HHS; AI57083 United States AI NIAID NIH HHS; GM112516 United States GM NIGMS NIH HHS
فهرسة مساهمة: Keywords: Antiretroviral drug discovery; HIV Nef; HIV-1; Nef inhibitors
المشرفين على المادة: 0 (Anti-HIV Agents)
0 (Small Molecule Libraries)
0 (nef Gene Products, Human Immunodeficiency Virus)
تواريخ الأحداث: Date Created: 20160208 Date Completed: 20161005 Latest Revision: 20181113
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC4756635
DOI: 10.1016/j.bmcl.2016.01.043
PMID: 26852364
قاعدة البيانات: MEDLINE
الوصف
تدمد:1464-3405
DOI:10.1016/j.bmcl.2016.01.043